Search

CANNABIS: NON-ADDICTIVE PATHWAY TO PAIN RELIEF?

New research suggests an avenue for developing treatments for chronic pain that harness the medicinal properties of cannabis while...

 
 
 

STEROID DISCOVERED IN DOGFISH SHARKS ATTACKS PARKINSON'S-RELATED TOXIN IN ANIMAL MODEL

A synthesized steroid mirroring one naturally made by the dogfish shark prevents the buildup of a lethal protein implicated in some...

BENITEC RELEASE: PHARMA RECEIVES ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR BB-301, A DDRNAI THERAPEUTIC IN DEVELOPMENT FOR THE TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY

Life Sciences Jobs ...

 
 
 

PRODUCTION OF HUMAN PRO-RELAXIN H2 IN THE YEAST PICHIA PASTORIS

Initially known as the reproductive hormone, relaxin was shown to possess other therapeutically useful properties that include extracellular...

C60 FULLERENE AS PROMISING THERAPEUTIC AGENT FOR CORRECTING AND PREVENTING SKELETAL MUSCLE FATIGUE

Bioactive soluble carbon nanostructures, such as the C60 fullerene can bond with up to six electrons, thus serving by a powerful scavenger...

 
 
 
 
 
 
Venture Investment in Seattle Area Companies Falls 27 Percent in 2016

VENTURE INVESTMENT IN SEATTLE AREA COMPANIES FALLS 27 PERCENT IN 2016

Two quarters do not make a trend, but the Seattle metro area bucked a national downturn in venture capital investment during the second...

Much Ado About Therapeutic Diets

MUCH ADO ABOUT THERAPEUTIC DIETS

A recent lawsuit underscores the lack of understanding about therapeutic diets that can only be purchased through a veterinarian

 
 
 
Austin Biotech Xeris Names Edick CEO, Raises $41M in Series C Round

AUSTIN BIOTECH XERIS NAMES EDICK CEO, RAISES $41M IN SERIES C ROUND

Austin -Xeris Pharmaceuticals, an Austin biotech, has raised $41 million in a Series C funding round and named a new CEO. Paul Edick...

HALOZYME PROVIDES PROGRAM UPDATES, 2017 FINANCIAL GUIDANCE AT 35TH ANNUAL JP MORGAN HEALTHCARE CONFERENCE

SAN DIEGO, Jan. 9, 2017 /PRNewswire/ - Halozyme Therapeutics, Inc. , a biotechnology company developing novel oncology and drug-delivery...

 
 
 

ARIDIS PHARMACEUTICALS RECEIVES AWARD FROM THE CYSTIC FIBROSIS FOUNDATION THERAPEUTICS TO ADVANCE PANAECIN

Award Supports Development Through Phase 2a Clinical Trials SAN JOSE, Calif., Jan. 9, 2017 /PRNewswire/ - Aridis Pharmaceuticals, Inc....

WHAT YOU NEED TO KNOW ABOUT BLADE THERAPEUTICS

January 9, 2017 By Mark Terry , BioSpace.com Breaking News Staff

 
 
 
 
 
 
Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines

NEON THERAPEUTICS HAULS IN $70M FOR PERSONALIZED CANCER VACCINES

One of the challenges of enlisting the body's immune system to fight cancer is the constant mutation of the disease. If the body's...

 
 
 
Video Game Offers Promising Results for Treating Depression

VIDEO GAME OFFERS PROMISING RESULTS FOR TREATING DEPRESSION

The study focuses on improving depression by cognitive control through the use of therapeutic video game technology.